NOTES TO THE CONSOLIDATED AND SEPARATE FINANCIAL STATEMENTS STATEMENTS
- Material accounting policies
- Material accounting estimates and assumptions
- Financial risk management
- Segment information
- Property and equipment
- Investment property
- Intangible assets
- Financial instruments
- Investments in associates and joint ventures
- Investments in subsidiaries
- Deferred tax
- Inventories
- Other financial assets
- Issued capital
- Other reserves
- Non-controlling interest
- Employment benefit liability
- Revenue
- Cost of pharmaceutical products and finished goods
- Profit before taxation
- Net finance costs
- Income tax expense/(credit)
- Earnings per share
- Cash flows from operating activities
- Income tax paid
- Dividends
- Share-based payments
- Contingencies, commitments and guarantees
- Related party transactions
- Pensions and other retirement obligations
- Contingent consideration
- Subsequent events
- Going concern
- Restatements of June 2023 and June 2022 results
- IFRS 17 insurance contracts
- Changes in liabilities arising from financing activities
- Other liabilities